Securing federal funding for breast cancer research and programs has never been more important. Komen’s Center for Public Policy is calling on lawmakers to prioritize essential breast cancer research and public health programs in Fiscal Year 2026 (FY26). In FY25, Congress made devastating cuts to biomedical research and left funding for critical services unprotected. Congress can make things right in FY26. Legislators need to hear from YOU that funding breast cancer research, screening, diagnosis, and treatment programs is critical.
Congress must invest in breast cancer programs at the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH) and Departments of Defense (DOD) to ensure the progress in reducing deaths from breast cancer continues.
Urge your lawmakers to preserve funding for these life-saving programs in FY26!
Thanks for trying to take action! There’s no need to act on this campaign because either your elected officials were not included or there’s currently a vacancy in your district.
Thanks for trying to take action! Unfortunately, we could not send your message because:
None of the officials targeted in this campaign accept the type of communication chosen by your organization.
No further action is needed at this time. Thank you again.
Your message has not been sent!
Your officials require the following additional information to be submitted in order for this message to be delivered to them.
The prefix you selected is not accepted by at least one of your legislators. Please choose one of the following prefixes: